Drug-resistant tuberculosis increasing among U.S. immigrant populations

NewsGuard 100/100 Score

Although tuberculosis rates have declined in the U.S., drug-resistant strains of the disease are becoming increasingly prevalent in states with large immigrant populations, the AP/Google.com reports.

According to the AP/Google.com, the increase in drug-resistant TB comes as funding for TB programs in cities such as San Francisco, which has the highest TB rates nationwide, is being reduced, prompting concern among TB researchers.

Immigrants living in states such as California are particularly vulnerable to drug-resistant TB because many people frequently travel to countries with higher TB prevalence -- such as China, India or Mexico -- or were born in such countries. California recorded 2,696 TB cases in 2008 and 451 cases of drug-resistant TB between 1993 and 2007. About 83% of drug-resistant cases recorded in the state involved foreign-born immigrants, the AP/Google.com reports (Barbassa, AP/Google.com, 3/22). According to CDC, TB incidence in California was about seven cases per 100,000 people in 2008, compared with 4.2 cases per 100,000 people nationwide during the same year (Lin, Los Angeles Times, 3/22). In addition, a statewide analysis of drug-resistant TB cases between 1993 and 2006 found that the proportion of patients who could develop extensively drug-resistant TB increased from 7% to 33%. XDR-TB is resistant to two of the most potent first-line treatments and at least two of the classes of second-line drugs.

"California, having so much exposure to the world via immigration and travel, is particularly at risk," Gil Chavez, deputy director of the California Department of Public Health, said. Jennifer Grinsdale, program manager and epidemiologist with the TB control section of the San Francisco Department of Public Health, said recent budget cuts have hindered the city's ability to administer TB tests proactively to diagnose and treat latent TB cases in high-risk areas. "Anywhere from two to 10 years from now, we'll see the impact for this," Grinsdale said (AP/Google.com, 3/22).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals BCG vaccine's unexpected role in fighting influenza